Navigation Links
Saladax Biomedical, Inc. Announces Pacific Rim Commercialization Team in Australia and China
Date:5/9/2011

BETHLEHEM, Pa., QUEENSLAND, Australia and BEIJING, May 9, 2011 /PRNewswire/ -- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today the formation of its Pacific Rim commercialization team to expand its presence in Australia and China.

Members of Saladax's Pacific Rim commercialization team include:

  • Yunying Li, Ph.D. (Saladax Biomedical, Inc.) – Dr. Li, Director of Market Development, Asia, with Saladax Biomedical, has held leadership roles in the Company since 2004.  Until 2010, she served as Research Group Leader, supervising product development efforts of the MyCare™ assay development group.  Prior to Saladax, Dr. Li was a senior research scientist at OraSure Technologies, Inc.  Dr. Li has relocated to Beijing where, utilizing her technical experience with the MyCare line and her cultural ties in China, she will lead the establishment of Saladax's commercial presence in this important market.  

  • Patrick Cook (Macarthur Cook Group Pty Ltd) – Mr. Cook is Principal at Macarthur Cook Group Pty Ltd, a privately held company in Queensland, Australia, which provides business development, education and training services.  Mr. Cook's extensive experience in the Australian diagnostic industry will help Saladax expand its sales and marketing efforts in Australia.  Mr. Cook serves as director and board member of IVD Australia Ltd., a leader in Australia's in vitro diagnostic industry.  He has worked with multiple international and local organizations including Roche Diagnostics, Quidel, Abbott Diagnostics and Royal Brisbane & Women's Hospital.

"With Dr. Li's extensive experience working with Saladax and Mr. Cook's significant know
'/>"/>

SOURCE Saladax Biomedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Saladax Biomedicals 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
2. Binder Biomedical, Inc. Announces the Release of the X-GRAFT(TM) Interspinous Device, as Part of Their QUANTUM(TM) Line of Spinal Allograft Devices, Manufactured at the University of Miami Tissue Bank
3. BINDER BIOMEDICAL, INC. Announces Official Launch of the NEWTON™ Intervertebral Body Fusion Spinal Spacer System
4. Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... MELVILLE, N.Y. , April 1, 2015  Henry ... provider of health care products and services to office-based ... completion of its acquisition of scil animal care company ... of animal health laboratory and imaging diagnostic products and ... and Europe.  This transaction was announced on ...
(Date:3/31/2015)... 2015 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... exclusive collaboration and licensing agreement for the development and ... Japan and other select Asian markets with ... to initially develop NBI-98854 in Japan ... tardive dyskinesia. Neurocrine retains full commercial rights to NBI-98854 ...
(Date:3/31/2015)... , March 31, 2015  The increasing ... applications have driven the need for automated ... automated segments are going to replace the ... This study provides the market overview, market ... key trends for the liquid handling market ...
Breaking Medicine Technology:Henry Schein Completes Acquisition of scil animal care 2Henry Schein Completes Acquisition of scil animal care 3Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 2Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 3Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 4Western European Liquid Handling Market 2
... YORK, July 19, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0574348/European-Medical-Displays-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging This research ... market in terms of the challenges faced ...
... drug companies face a number of obstacles to commercialize ... (FDA) and GMP compliance, to distribution agreements and the ... must be coordinated.  Those issues have just become easier ... VPCI have entered into a joint association.  The collaboration ...
Cached Medicine Technology:European Medical Displays Markets 2European Medical Displays Markets 3European Medical Displays Markets 4Spanish Drug Companies Have New Support Option for the U.S. Market 2
(Date:4/1/2015)... MEETING, PA (PRWEB) April 01, 2015 ... assistance company and a subsidiary of West Corporation, today ... available at http://blog.healthadvocate.com and through the Health ... help healthcare consumers get, and stay, healthy. , “We’re ... contents available to the public,” said Martin Rosen, Executive ...
(Date:4/1/2015)... 2015 Senior Helpers of Central Texas ... Provider of Choice Award by Home Care Pulse. The Best ... given to home care providers who receive the highest satisfaction ... quality in home care. This recognition reassures you that your ... provide you with quality, trustworthy in home care. , In ...
(Date:4/1/2015)... York (PRWEB) April 01, 2015 On May ... will host its annual Educational Institute in Albany, New ... innovations, and initiatives in nursing and feature an address by ... Jean M. Hill Professor, University of Kansas School of Nursing ... The event is being sponsored by the Excelsior College School ...
(Date:4/1/2015)... 2015 Franklin University, one of the ... the establishment of the Greta J. Russell Medical Mutual ... through the generous gift of $100,000 from Medical Mutual ... of Medical Mutual to University representatives, Dr. David ... Advancement & Strategic Relations. , “We are grateful ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 ScooterDirect.com is ... mobility scooters to improve their customers’ lifestyle using electric ... to the special needs of the people, they provide ... people to become independent and enjoy their freedom. Scooterdirect.com ... Scooter at discounted prices. , One of ...
Breaking Medicine News(10 mins):Health News:Health Advocate Launches New Health and Wellness Blog 2Health News:Senior Helpers of Central Texas Awarded Prestigious 2015 Senior Home Care Provider of Choice Award from Home Care Pulse 2Health News:Excelsior College School of Nursing Educational Institute to Influence Nursing Empowerment 2Health News:Excelsior College School of Nursing Educational Institute to Influence Nursing Empowerment 3Health News:Franklin University Receives Gift to Create the Greta J. Russell Medical Mutual of Ohio Scholarship 2Health News:Franklin University Receives Gift to Create the Greta J. Russell Medical Mutual of Ohio Scholarship 3Health News:ScooterDirect.com Offering Pride Go Go Traveller Elite 3 Wheel Scooter 2
... Self-Funding Healthcare Conference and Expo will provide employers and ... options during a June 1-3, 2009 conference in Kansas ... an employer rather than a conference promoter. ... the event to help educate employers and plan sponsors ...
... of imaging techniques, the accuracy of preoperative rectal cancer ... function in rectal cancer patients has become a very ... to be published on March 14, 2009 in the ... factors for 5-year survival after local excision of rectal ...
... typical backgrounds of the patients are diagnosed by radiological ... diagnostic imaging techniques. A typical LCA shows low density ... contrasting effect on arterial phase and does not show ... LCA in magnetic resonance imaging shows almost the same ...
... with atrial fibrillation. In the current edition of ... 164-70), Thomas Bitter and his coauthors from the Ruhr ... in this form of cardiac arrythmia and what the ... polygraphy to investigate whether 150 patients (110 men and ...
... Balance SheetATLANTA, March 20 In a time when ... healthcare centers are finding themselves in the same position ... of available financing is putting a damper on major ... the world,s leading manufacturers of oncology and neurosurgical devices ...
... March 20 Boehringer Ingelheim today announced that ... Phase III Randomized Evaluation of Long term Anticoagulant ... efficacy and safety of the oral direct thrombin ... warfarin (target international normalized ratio, INR, 2-3) for ...
Cached Medicine News:Health News:Deffenbaugh Industries to Host Self-Funding Healthcare Conference in Kansas City 2Health News:Elekta Finds New Interest in Leasing Solutions as Hospitals Debate Capital Purchases 2Health News:Elekta Finds New Interest in Leasing Solutions as Hospitals Debate Capital Purchases 3Health News:Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date 2Health News:Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date 3Health News:Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date 4
The Redi-glaze spectacle magnifier is an aspheric lens, glazed into a standard Keeler LVA frame....
A simple testing set for prescribing aspheric spectacle magnifiers. Redi-glaze lenses are available for instant dispensing which are cut and edged to fit our standard LVA frame....
... Featuring up to ... allows examination in the ... sections plus the option ... for corneal transillumination., ,Filters ...
... on the outstanding optical system of the ... an external fibre optic illumination system with ... a digital camera. The result is an ... ,With the option of capturing stills or ...
Medicine Products: